BreatheWell: Train Your Breathing, Relax Your Body, Open Your Mind
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Apr 7, 2025
Trial Information
Current as of August 20, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study seeks to investigate the impact of daily inspiratory muscle training (IMT) over 12 weeks on mental and physical well-being, focusing on whether the effects are sustained three months post-intervention. IMT is a breathing exercise known to improve respiratory function and reduce stress. This research will expand on previous findings showing that IMT can influence psychological states, such as increased awareness of the body, and improved relaxation and well-being. The investigators aim to compare the effects of IMT against a sham IMT group and a health data engagement-only group, ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 or higher
- • Stable health for the past 3 months.
- Exclusion Criteria:
- • IMT contraindications which relate to people who should not raise lung, thoracic, or sinus pressures
- • Current or recent (\< 3 months) use of cardiovascular or psychotropic medications
- • Diagnosed psychotic disorders
- • Current participation in therapy
- • Recent initiation of mind-body practice
- • Current major illness or injury
- • Regular use of personal tracking devices to monitor sleep, heart rate, activity, or related physiological data.
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Paul Macey, PhD
Principal Investigator
Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported